|
1
|
Ambros V: MicroRNAs: Tiny regulators with
great potential. Cell. 107:823–826. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guarnieri DJ and DiLeone RJ: MicroRNAs: A
new class of gene regulators. Ann Med. 40:197–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cichocki F, Felices M, McCullar V,
Presnell SR, Al-Attar A, Lutz CT and Miller JS: Cutting edge:
MicroRNA-181 promotes human NK cell development by regulating Notch
signaling. J Immunol. 187:6171–6175. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ziętara N, Łyszkiewicz M, Witzlau K,
Naumann R, Hurwitz R, Langemeier J, Bohne J, Sandrock I, Ballmaier
M, Weiss S, et al: Critical role for miR-181a/b-1 in agonist
selection of invariant natural killer T cells. Proc Natl Acad Sci
USA. 110:7407–7412. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Henao-Mejia J, Williams A, Goff LA, Staron
M, Licona-Limón P, Kaech SM, Nakayama M, Rinn JL and Flavell RA:
The microRNA miR-181 is a critical cellular metabolic rheostat
essential for NKT cell ontogenesis and lymphocyte development and
homeostasis. Immunity. 38:984–997. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li QJ, Chau J, Ebert PJ, Sylvester G, Min
H, Liu G, Braich R, Manoharan M, Soutschek J, Skare P, et al:
miR-181a is an intrinsic modulator of T cell sensitivity and
selection. Cell. 129:147–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Belkaya S and van Oers NS: Transgenic
expression of microRNA-181d augments the stress-sensitivity of
CD4(+)CD8(+) thymocytes. PLoS One. 9:e852742014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Choong ML, Yang HH and McNiece I: MicroRNA
expression profiling during human cord blood-derived CD34 cell
erythropoiesis. Exp Hematol. 35:551–564. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Zhang J, Gao L, McClellan S, Finan
MA, Butler TW, Owen LB, Piazza GA and Xi Y: MiR-181 mediates cell
differentiation by interrupting the Lin28 and let-7 feedback
circuit. Cell Death Differ. 19:378–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pekarsky Y, Santanam U, Cimmino A,
Palamarchuk A, Efanov A, Maximov V, Volinia S, Alder H, Liu CG,
Rassenti L, et al: Tcl1 expression in chronic lymphocytic leukemia
is regulated by miR-29 and miR-181. Cancer Res. 66:11590–11593.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA, Pekarsky Y and Croce CM: The
role of microRNA and other non-coding RNA in the pathogenesis of
chronic lymphocytic leukemia. Best Pract Res Clin Haematol.
20:425–437. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marcucci G, Maharry K, Radmacher MD,
Mrózek K, Vukosavljevic T, Paschka P, Whitman SP, Langer C, Baldus
CD, Liu CG, et al: Prognostic significance of, and gene and
microRNA expression signatures associated with, CEBPA mutations in
cytogenetically normal acute myeloid leukemia with high-risk
molecular features: A Cancer and Leukemia Group B Study. J Clin
Oncol. 26:5078–5087. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li Z, Huang H, Li Y, Jiang X, Chen P,
Arnovitz S, Radmacher MD, Maharry K, Elkahloun A, Yang X, et al:
Up-regulation of a HOXA-PBX3 homeobox-gene signature following
down-regulation of miR-181 is associated with adverse prognosis in
patients with cytogenetically abnormal AML. Blood. 119:2314–2324.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan XN, Chen JJ, Wang LX, Xiao RZ, Liu LL,
Fang ZG, Liu Q, Long ZJ and Lin DJ: Inhibition of c-Myc overcomes
cytotoxic drug resistance in acute myeloid leukemia cells by
promoting differentiation. PLoS One. 9:e1053812014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Liu X, Xiao F, Xue S, Xu Q, Yin Y,
Sun H, Xu J, Wang H, Zhang Q, Wang H and Wang L: Spred2 modulates
the erythroid differentiation induced by imatinib in chronic
myeloid leukemia cells. PLoS One. 10:e01175732015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kastrati I, Canestrari E and Frasor J:
PHLDA1 expression is controlled by an estrogen
receptor-NFκB-miR-181 regulatory loop and is essential for
formation of ER+ mammospheres. Oncogene. 34:2309–2316. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pichler M, Winter E, Ress AL, Bauernhofer
T, Gerger A, Kiesslich T, Lax S, Samonigg H and Hoefler G: miR-181a
is associated with poor clinical outcome in patients with
colorectal cancer treated with EGFR inhibitor. J Clin Pathol.
67:198–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: hsa-miR-181a and hsa-miR-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFβ-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song MK, Park YK and Ryu JC: Polycyclic
aromatic hydrocarbon (PAH)-mediated upregulation of hepatic
microRNA-181 family promotes cancer cell migration by targeting
MAPK phosphatase-5, regulating the activation of p38 MAPK. Toxicol
Appl Pharmacol. 273:130–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neel JC and Lebrun JJ: Activin and TGFβ
regulate expression of the microRNA-181 family to promote cell
migration and invasion in breast cancer cells. Cell Signal.
25:1556–1566. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mansueto G, Forzati F, Ferraro A, Pallante
P, Bianco M, Esposito F, Iaccarino A, Troncone G and Fusco A:
Identification of a new pathway for tumor progression:
MicroRNA-181b up-regulation and CBX7 down-regulation by HMGA1
protein. Genes Cancer. 1:210–224. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P
and Hu W: MicroRNA-181a sensitizes human malignant glioma U87MG
cells to radiation by targeting Bcl-2. Oncol Rep. 23:997–1003.
2010.PubMed/NCBI
|
|
25
|
Mosakhani N, Mustjoki S and Knuutila S:
Down-regulation of miR-181c in imatinib-resistant chronic myeloid
leukemia. Mol Cytogenet. 6:272013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ouyang YB, Lu Y, Yue S and Giffard RG:
miR-181 targets multiple Bcl-2 family members and influences
apoptosis and mitochondrial function in astrocytes. Mitochondrion.
12:213–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Naguibneva I, Ameyar-Zazoua M, Polesskaya
A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S and Harel-Bellan
A: The microRNA miR-181 targets the homeobox protein Hox-A11 during
mammalian myoblast differentiation. Nat Cell Biol. 8:278–284. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Z, Jiang J, Xu C, Wang Y, Sun L, Guo X
and Liu H: MicroRNA-181 regulates CARM1 and histone arginine
methylation to promote differentiation of human embryonic stem
cells. PLoS One. 8:e531462013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bhushan R, Grünhagen J, Becker J, Robinson
PN, Ott CE and Knaus P: miR-181a promotes osteoblastic
differentiation through repression of TGF-β signaling molecules.
Int J Biochem Cell Biol. 45:696–705. 2013. View Article : Google Scholar : PubMed/NCBI
|
